Keratitis: Clinical Trials

218 trials for Keratitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

152 completed, 30 unknown, 14 withdrawn, 8 recruiting. 54 Not applicable, 46 Phase 3, 45 Phase 2, 21 Phase 4, 17 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable54Completed 36, Unknown 7, Withdrawn 5, Terminated 4, Recruiting 2
Phase 346Completed 37, Unknown 6, Recruiting 2, Withdrawn 1
Phase 245Completed 33, Terminated 3, Unknown 3, Not yet recruiting 2, Recruiting 2, Withdrawn 2
Phase 421Completed 16, Withdrawn 4, Terminated 1
Phase 117Completed 12, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Early Phase 12Completed 1, Unknown 1

Follow Keratitis: new trials by email Literature Review of Keratitis trials Research Report on Keratitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fluorometholone Study
Adjunctive Topical Fluorometholone (FML) 0.1%, Standard Topical Antibiotic Therapy - Keratitis Bacterial, Corneal Ulcer (Diagnosis)
Phase 2Not yet recruitingVishal Jhanji1742026-10-312026-06-10
Clinical Predictors of Visual Outcome in Patients Affected With Ocular Surface Diseases
Neurotrophic Keratopathy, Exposure Keratopathy
Not yet recruitingIRCCS San Raffaele10002026-07-012026-07-14
Follow-up Compliance for Corneal Ulcer Patients With SMS Reminder
SMS reminder - Corneal Ulcer
Not applicableRecruitingSeva Canada Society3102026-02-232026-05-12
Open-label Prospective Clinical Trial Evaluating the Safety and Efficacy of Biosynthetic CLP-PEG-MPC Corneal Implants in Patients Undergoing High-risk Deep Anterior Lamellar Keratoplasty.
CLP-PEG-MPC, Human donor cornea penetrating keratoplasty - High-risk Corneal Transplantation, Corneal Blindess
Not applicableWithdrawnCentre hospitalier de l'Université de Montréal (CHUM)2026-01-012022-12-28
Pattern of Microbial Keratitis in Assiut University Hospital
corneal scraping including direct smear, culture and sensitivity - Keratitis, Microbial Keratitis
Not yet recruitingAssiut University1002026-01-012026-01-05
A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
BRM421 Ophthalmic Solution, 0.03%, Artificial Tear, BRM421 Ophthalmic Solution, 0.06% - Dry Eye Disease (DED), Keratoconjunctivitis Sicca
Phase 2Not yet recruitingBRIM Biotechnology Inc.992025-12-012025-10-20
Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.
PHMB 0.08% - Acanthamoeba Keratitis
CompletedSIFI SpA232025-10-302026-06-22
Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
Intrastromal anti-VEGF injection and topical antiviral eye drops, Conventional antiviral topical ocular drops. - Herpes Simplex Keratitis, Corneal Neovascularization
Phase 1 / Phase 2RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1002025-10-012026-01-09
Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis
Intrastromal moxifloxacin injection plus standard topical moxifloxacin therapy, Standard topical moxifloxacin therapy alone - Bacterial Keratitis, Recalcitrant Infectious Keratitis
Not applicableRecruitingMinia University602025-10-012026-09-10
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Cyclosporine A, Placebo Comparator: Placebo - Fungal Keratitis, Corneal Ulcer
Phase 3RecruitingUniversity of California, San Francisco1502025-09-012026-06-05
Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed
Reinnerva/Lubristil +G sterile eye drops (artificial tears), Vismed sterile eye drops (artificial tears) - Keratoconjunctivitis Sicca
Not applicableCompletedMedivis SRL402025-06-092026-02-19
Corneal Topography in Vernal Keratoconjunctivitis
pentacam - Keratoconjunctivitis
Not yet recruitingAssiut University442025-06-012024-12-24
Diagnosing Corneal Infection
Corneal impression membrane (Millicell Cell Culture Insert, 12mm, hydrophilic PTFE 0.4µm (PICM01250)) - Corneal Ulcer (Diagnosis)
WithdrawnUniversity of Edinburgh2025-02-012026-02-27
Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis
Acyclovir 400 MG, Ganciclovir (GCV) - Herpetic Keratitis
Not applicableCompletedAl-Azhar University202024-10-012025-01-03
Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/ml Polihexanide
Acanthamoeba Keratitis
CompletedSIFI SpA402024-09-302025-10-01
Parasitic Ulcer Treatment Trial
Polyhexamethylene biguanide (PHMB), Topical corticosteroid, Topical placebo - Acanthamoeba Keratitis
Phase 3RecruitingJeremy Keenan, MD, MPH2322024-07-012026-10-01
Acanthamoeba and Artificial Intelligence
Acanthamoeba Keratitis, Artificial Intelligence
UnknownIRCCS Ospedale San Raffaele1512024-05-012024-05-10
Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis
OXERVATE® 0.002% - Neurotrophic Keratitis, Neurotrophic Keratopathy
Phase 4WithdrawnDompé Farmaceutici S.p.A2024-04-262024-12-02
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
INV-102, Vehicle - Dry Eye Disease
Phase 2CompletedInvirsa, Inc.1092024-03-272026-09-18
Vizol S DIGI EYE Efficacy and Safety Study in Patients With Dry Eye
Vizol S DIGI EYE eye drops, 0,9% saline solution, eye drops - Dry Eye Disease (DED)
Phase 3CompletedJadran Galenski laboratorij d.d.862024-03-202025-07-03

Showing 20 of 218. Sign in to see all of them.

Narrower conditions

Keratoconjunctivitis Sicca (85)  ·  Dry Eye Syndromes (75)  ·  Corneal Ulcer (55)  ·  Corneal Diseases (19)  ·  Keratoconjunctivitis (17)  ·  Conjunctivitis (14)  ·  Keratitis, Herpetic (13)  ·  Acanthamoeba Keratitis (10)  ·  Sjogren's Syndrome (10)  ·  Eye Diseases (9)  ·  Cataract (6)  ·  Pterygium (6)  ·  Blepharitis (5)  ·  Corneal Dystrophies, Hereditary (5)

Broader conditions

Eye Diseases (209)  ·  Corneal Diseases (199)  ·  Conjunctival Diseases (115)  ·  Conjunctivitis (97)  ·  Lacrimal Apparatus Diseases (93)  ·  Infections (90)  ·  Keratoconjunctivitis (84)  ·  Eye Infections (83)  ·  Pathological Conditions, Signs and Symptoms (24)  ·  Dry Eye Syndromes (19)  ·  Virus Diseases (19)  ·  DNA Virus Infections (18)  ·  Herpesviridae Infections (16)  ·  Skin and Connective Tissue Diseases (16)

Interventions

Lubricant Eye Drops (9)  ·  Cyclosporine (6)  ·  Loteprednol Etabonate (6)  ·  Ophthalmic Solutions (6)  ·  Cyclosporins (5)  ·  Acyclovir (4)  ·  Adrenal Cortex Hormones (4)  ·  Fluorometholone (4)  ·  Moxifloxacin (4)  ·  Riboflavin (4)  ·  rebamipide (4)  ·  Corneal Cross-Linking (3)  ·  Dexamethasone (3)  ·  Ganciclovir (3)  ·  Hyaluronic Acid (3)

Sponsors

University of California, San Francisco (9)  ·  National Eye Institute (NEI) (7)  ·  Allergan (5)  ·  National Taiwan University Hospital (4)  ·  Oculeve, Inc. (4)  ·  SIFI SpA (4)  ·  Sun Pharmaceutical Industries Limited (4)  ·  Assiut University (3)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (3)  ·  Federal University of São Paulo (3)  ·  Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA (3)  ·  Kala Pharmaceuticals, Inc. (3)  ·  Mimetogen Pharmaceuticals USA, Inc. (3)  ·  Minia University (3)  ·  Mitotech, SA (3)

Countries

United States (94)  ·  France (14)  ·  China (13)  ·  India (12)  ·  Egypt (10)  ·  Taiwan (9)  ·  Brazil (8)  ·  Spain (8)  ·  United Kingdom (8)  ·  Austria (5)  ·  Italy (5)  ·  Germany (4)  ·  Nepal (4)  ·  Denmark (3)  ·  Israel (3)

Top investigators

Gail Torkildsen, MD (4)  ·  Tom Lietman, MD (3)  ·  Bala Ambati (2)  ·  Garth Cumberlidge, PhD (2)  ·  Gary Foulks, MD (2)  ·  Jennifer Rose-Nussbaumer, MD (2)  ·  Jodi Luchs, MD (2)  ·  Lawrence T Friedhoff, MD, PhD (2)  ·  Michelle Senchyna (2)  ·  NV Prajna, DNB, FRC Ophth (2)  ·  Nisha Acharya, MD, MS (2)  ·  Robert Shalwitz, MD (2)  ·  Yvette Viscuso (2)

Results publications

PMID 32557558, PMID 23062001, PMID 30472141, PMID 34483270, PMID 35024776, PMID 10832689, PMID 11285665, PMID 11520759, PMID 12131029, PMID 12386069, PMID 12515932, PMID 15355406, PMID 15829742, PMID 15948994, PMID 16021174, PMID 16322853, PMID 16575115, PMID 16926355, PMID 17054241, PMID 17258535, PMID 17583820, PMID 17657018, PMID 18204773, PMID 18245962, PMID 18608899, PMID 18829631, PMID 19097643, PMID 19730094, PMID 1985498, PMID 20304499, PMID 20547942, PMID 20631232, PMID 20847116, PMID 20944931, PMID 21109229, PMID 21310379, PMID 21320979, PMID 21836342, PMID 21966201, PMID 21987582, PMID 22159005, PMID 22256909, PMID 22378109, PMID 22395880, PMID 22447793, PMID 22511024, PMID 22959881, PMID 23307105, PMID 23307204, PMID 23355529

NIH funding

U10EY018573 (2), R01EY031033 (1), R34EY017626 (1), U10EY015114 (1), U10EY022880 (1), UG1EY028518 (1), UG1EY033284 (1)